CYPROTERONE/ETHINYLESTRADIOL AND CONCOMITANT USE OF OTHER HORMONAL CONTRACEPTIVES IN THE NETHERLANDS

Author(s)

Bezemer ID¹, Smits L¹, Penning-van Beest F¹, Asiimwe A², Herings RM¹
¹PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands, ²Bayer Pharma AG, Berlin, Germany

Presentation Documents

PIH37--strong-u-bezemer-id-u-sup-1-sup-strong-smits-l-sup-1-sup-penning-van-beest-f-sup-1-sup-asiimwe-a-sup-2-sup-herings-rm-sup-1-sup-br-sup-1-sup-pharmo-institute-for-drug-outcomes-research-utrecht-the-netherlands-sup-2-sup-bayer-pharma-a ...

Conference/Value in Health Info

2016-10, ISPOR Europe 2016, Vienna, Austria

Value in Health, Vol. 19, No. 7 (November 2016)

Code

PIH37

Topic

Health Service Delivery & Process of Care

Topic Subcategory

Prescribing Behavior

Disease

Reproductive and Sexual Health

Explore Related HEOR by Topic

Healthcare Delivery

Presentation